These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35692348)

  • 1. Methods for Improving the Variance Estimator of the Kaplan-Meier Survival Function, When There Is No, Moderate and Heavy Censoring-Applied in Oncological Datasets.
    Khan HN; Zaman Q; Azmi F; Shahzada G; Jakovljevic M
    Front Public Health; 2022; 10():793648. PubMed ID: 35692348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple hybrid variance estimator for the Kaplan-Meier survival function.
    Borkowf CB
    Stat Med; 2005 Mar; 24(6):827-51. PubMed ID: 15558837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interval-specific censoring set adjusted Kaplan-Meier estimator.
    Wu Y; Kolassa J
    J Appl Stat; 2024; 51(12):2436-2456. PubMed ID: 39267713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules.
    Eaton AA; Zabor EC
    Stat Med; 2022 Apr; 41(9):1599-1612. PubMed ID: 35043427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kaplan-Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average.
    Satten GA; Datta S
    Am Stat; 2001; 55(3):207-210. PubMed ID: 28845048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted Kaplan-Meier estimators motivating to estimate HIV-1 RNA reduction censored by a limit of detection.
    Ahmed I; Flandre P
    Stat Med; 2020 Mar; 39(7):968-983. PubMed ID: 31981243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Expectation-Maximization Algorithm for Including Oncological COVID-19 Deaths in Survival Analysis.
    De Felice F; Mazzoni L; Moriconi F
    Curr Oncol; 2023 Feb; 30(2):2105-2126. PubMed ID: 36826124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical Comparison of the Breslow Estimator and the Kalbfleisch Prentice Estimator for Survival Functions.
    Xia F; Ning J; Huang X
    J Biom Biostat; 2018; 9(2):. PubMed ID: 30370174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.
    Fay MP; Brittain EH; Proschan MA
    Biostatistics; 2013 Sep; 14(4):723-36. PubMed ID: 23632624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of reinforced urn processes under left-truncation and right-censoring.
    Souto Arias LA; Cirillo P; Oosterlee CW
    R Soc Open Sci; 2023 Mar; 10(3):221223. PubMed ID: 36908984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some insight on censored cost estimators.
    Zhao H; Cheng Y; Bang H
    Stat Med; 2011 Aug; 30(19):2381-8. PubMed ID: 21748774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous marginal survival estimators when doubly censored data is present.
    Julià O; Gómez G
    Lifetime Data Anal; 2011 Jul; 17(3):347-72. PubMed ID: 20886370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of parametric and semi-parametric models with randomly right-censored data by weighted estimators: Two applications in colon cancer and hepatocellular carcinoma datasets.
    Yenilmez İ; Yılmaz E; Kantar YM; Aydın D
    Stat Methods Med Res; 2022 Feb; 31(2):372-387. PubMed ID: 34903099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The homogenetic estimate for the variance of survival rate.
    Zhao G
    Stat Med; 1996 Jan; 15(1):51-60. PubMed ID: 8614745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis using auxiliary variables via non-parametric multiple imputation.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to the Kaplan-Meier estimator of progression-free survival.
    Zhang JJ; Sun Z; Yuan H; Wang M
    Int J Biostat; 2020 Sep; 17(1):99-115. PubMed ID: 32892174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric survival estimation when death is reported with delay.
    Hubbard AE; Van der Laan MJ; Enanoria W; Colford JM
    Lifetime Data Anal; 2000 Sep; 6(3):237-50. PubMed ID: 10949861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.